Strides Pharma Science

Strides Pharma Science FCF/Net Income

The Free Cash Flow to Net Income Ratio of Strides Pharma Science (STAR.NS) as of Nov 22, 2026 is 12.30 %. In the previous year, Free Cash Flow to Net Income Ratio was -825.33 % — a change of -101.49% (higher).

FCF/Net Income

12.30 %

YoY

-101.49%

Last updated:

Free Cash Flow to Net Income Ratio of Strides Pharma Science is 2025 12.30 % . Free Cash Flow to Net Income Ratio of Strides Pharma Science was 2024 -825.33 % . It decreases by -101.49% higher compared to the previous year.

The Strides Pharma Science FCF/Net Income history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Net Income
Date
FCF/Net Income
Jan 1, 2018
-34.77 INR
Jan 1, 2019
-82.88 INR
Jan 1, 2020
150.52 INR
Jan 1, 2021
68.54 INR
Jan 1, 2022
87.18 INR
Jan 1, 2023
25.10 INR
Jan 1, 2024
-825.33 INR
Jan 1, 2025
12.30 INR
The Strides Pharma Science FCF/Net Income history
YEARFCF/Net IncomeYoY
12.30 %-101.49%
-825.33 %-3,387.85%
25.10 %-71.21%
87.18 %+27.20%
68.54 %-54.47%
150.52 %-281.62%
-82.88 %+138.39%
-34.77 %-85.11%
-233.42 %-9.41%
-257.66 %+1,273.03%
-18.77 %-58.10%
-44.79 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science Ltd. generates revenue through the development, manufacturing, and distribution of IP-led generics and bio-pharmaceutical products across its Pharmaceutical and Bio-pharmaceutical segments. The company serves global markets including Africa, Australia, Asia (excluding India), North America, Europe, India, and Others, offering niche pharmaceutical products in various dosage forms such as liquids, creams, ointments, soft gels, sachets, tablets, and modified release formats. Its manufacturing units in Bengaluru, Puducherry, Chennai, Singapore, Milan, Florida, and Nairobi produce anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drugs, alongside soft gelatin capsules. The firm's revenue streams are derived from the sale of its IP-led niche pharmaceutical products to healthcare providers, distributors, and global pharmaceutical companies operating in the specified geographical segments. Key product categories include anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments, which are distributed through its global manufacturing network. The company's focus on specialized drug segments ensures consistent demand from healthcare systems and institutions managing infectious diseases. Strides Pharma Science Ltd. targets healthcare institutions, distributors, and pharmaceutical companies in regions such as North America, Europe, India, and Africa, where infectious disease management requires specialized treatments. Its manufacturing presence in multiple countries supports direct market access and cost efficiency, enabling the delivery of affordable pharmaceutical solutions. The company's product portfolio emphasizes high-demand therapeutic areas, aligning with global health priorities for infectious disease treatment. Strides Pharma Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Strides Pharma Science stock

Free Cash Flow to Net Income Ratio of Strides Pharma Science is 12.30 % in 2025.

Free Cash Flow to Net Income Ratio of Strides Pharma Science changed from -825.33 % to 12.30 %, representing a -101.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Net Income Ratio Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

The FCF/Net Income ratio measures cash flow quality. Ratios consistently above 100% suggest high-quality earnings with strong cash backing.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Net Income Ratio's Strides Pharma Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow to Net Income Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow to Net Income Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Strides Pharma Science

All Key Metrics — Strides Pharma Science